Procalcitonin Level Evaluation for Prediction of Sepsis-Associated Mortality Rate in a Subset of Karachi Population
Procalcitonin Levels as Predictors of Sepsis-Associated Mortality
DOI:
https://doi.org/10.54393/pjhs.v7i1.3412Keywords:
Procalcitonin Level, Sepsis, Mortality, ELISA TechniqueAbstract
Procalcitonin (PCT) has been recognized as a crucial biomarker in the diagnosis and prognosis of sepsis, as it reflects the body's response to infection. Objective: To identify the association of procalcitonin level for the prediction of sepsis-associated mortality rate in a subset of the Karachi population. Methods: It was an analytical cross-sectional study conducted at Ziauddin Medical College with approval of the ERC. The sample size was n=130. The set inclusion criteria were patients in whom sepsis was suspected, who given consent to participate in the study, and were within the range of 18-60 years. The exclusion criteria were patients from other hospitals, patients with malignancies and known ischemic heart diseases, patients with thyroid disorders, patients who had leukopenia, and patients who did not give consent to participate in the study. The data were collected through a pre-developed questionnaire, which included questions regarding demographics, presenting complaint, PCT levels at the time of admission, and outcome as positive (recovered) or negative (died). The minimum PCT levels considered as negative were 0.1 – 0.25ng/mL, if the outcome seemed to be positive. Results: Most of the patients with sepsis had 4-6 ng/mL of PCT levels. The increased mortality was found to be significantly associated with high levels of PCT, specifically in patients having PCT 6-8 ng/mL and greater than 8 ng/mL. Conclusions: High PCT levels can predict the outcome of sepsis; PCT levels more than 6 were associated with a high mortality rate in a subset of the Karachi population.
References
Nedeva C. Inflammation and Cell Death of the Innate and Adaptive Immune System During Sepsis. Biomolecules. 2021 Jul; 11(7): 1-15. doi: 10.3390/biom11071011. DOI: https://doi.org/10.3390/biom11071011
Liu Z, Ting Y, Li M, Li Y, Tan Y, Long Y. From Immune Dysregulation to Organ Dysfunction: Understanding the Enigma of Sepsis. Frontiers In Microbiology. 2024 Aug; 15: 1-15. doi: 10.3389/fmicb.2024.1415274 DOI: https://doi.org/10.3389/fmicb.2024.1415274
Srivastava V and Singh S. Organ Support in Sepsis: A Panoramic View from Infection to Death. Medical Journal Armed Forces India. 2024 Jan; 80(1): 4-9. doi: 10.1016/j.mjafi.2023.10.010. DOI: https://doi.org/10.1016/j.mjafi.2023.10.010
La Via L, Sangiorgio G, Stefani S, Marino A, Nunnari G, Cocuzza S et al. The Global Burden of Sepsis and Septic Shock. Epidemiologia. 2024 Jul; 5(3): 456-78. doi: 10.3390/epidemiologia5030032. DOI: https://doi.org/10.3390/epidemiologia5030032
Lippert AM. System Failure: The Geographic Distribution of Sepsis-Associated Death in The Usa and Factors Contributing to the Mortality Burden of Black Communities. Journal Of Racial and Ethnic Health Disparities. 2023 Oct; 10(5): 2397-406. doi: 10.1007/s40615-022-01418-z. DOI: https://doi.org/10.1007/s40615-022-01418-z
Kumar NR, Balraj TA, Kempegowda SN, Prashant A. Multidrug-Resistant Sepsis: A Critical Healthcare Challenge. Antibiotics. 2024 Jan; 13(1): 1-38. doi: 10.3390/antibiotics13010046. DOI: https://doi.org/10.3390/antibiotics13010046
Eichberger J, Resch E, Resch B. Diagnosis of Neonatal Sepsis: The Role of Inflammatory Markers. Frontiers In Pediatrics. 2022 Mar; 10: 1-13. doi: 10.3389/fped.2022.840288. DOI: https://doi.org/10.3389/fped.2022.840288
Park CE. Diagnosis and Prognosis of Sepsis. Korean Journal of Clinical Laboratory Science. 2021; 53(4): 309-16. doi: 10.15324/kjcls.2021.53.4.309. DOI: https://doi.org/10.15324/kjcls.2021.53.4.309
Malik M, Nair AS, Illango J, Siddiqui N, Gor R, Fernando RW et al. The Advancement in Detecting Sepsis and its Outcome: Usefulness of Procalcitonin in Diagnosing Sepsis and Predicting Fatal Outcomes in Patients Admitted to Intensive Care Unit. Cureus. 2021 Apr; 13(4): 1-10. doi: 10.7759/cureus.14439. DOI: https://doi.org/10.7759/cureus.14439
Liang P and Yu F. Value Of CRP, PCT, and NLR in Prediction of Severity and Prognosis of Patients with Bloodstream Infections and Sepsis. Frontiers in Surgery. 2022 Mar; 9: 1-7. doi: 10.3389/fsurg.2022.857218. DOI: https://doi.org/10.3389/fsurg.2022.857218
Yang X, Zeng J, Yu X, Wang Z, Wang D, Zhou Q et al. PCT, IL-6, and IL-10 Facilitate Early Diagnosis and Pathogen Classifications in Bloodstream Infection. Annals of Clinical Microbiology and Antimicrobials. 2023 Nov; 22(1): 1-13. doi: 10.1186/s12941-023-00653-4. DOI: https://doi.org/10.1186/s12941-023-00653-4
Cabral L, Fernandes M, Marques S, Meireles R, Caetano M, Afreixo V. PCT Kinetics in the First Week Postburn for Sepsis Diagnosis and Death Prognosis, An Accuracy Study. Journal of Burn Care and Research. 2021 May; 42(3): 545-54. doi: 10.1093/jbcr/iraa199. DOI: https://doi.org/10.1093/jbcr/iraa199
Tsui TL, Huang YT, Kan WC, Huang MS, Lai MY, Ueng KC et al. A Novel Procalcitonin-Based Score for Detecting Sepsis Among Critically Ill Patients. Plos One. 2021 Jan 22; 16(1): 1-15. doi: 10.1371/journal.pone.0245748. DOI: https://doi.org/10.1371/journal.pone.0245748
Suranadi IW, Sinardja CD, Suryadi IA. Role of Procalcitonin in Predicting Mortality and Organ Dysfunction at Intensive Care Admission. International Journal of General Medicine. 2022 May; 15: 4917-23. doi: 10.2147/IJGM.S362558. DOI: https://doi.org/10.2147/IJGM.S362558
Choe EA, Shin TG, Jo IJ, Hwang SY, Lee TR, Cha WC et al. The Prevalence and Clinical Significance of Low Procalcitonin Levels Among Patients with Severe Sepsis or Septic Shock in the Emergency Department. Shock. 2016 Jul; 46(1): 37-43. doi: 10.1097/SHK.0000000000000566. DOI: https://doi.org/10.1097/SHK.0000000000000566
Chambliss AB, Patel K, Colón-Franco JM, Hayden J, Katz SE, Minejima E. Woodworth A. American Association for Clinical Chemistry Guidance Document on the Clinical Use of Procalcitonin. The Journal of Applied Laboratory Medicine. 2023 May; 8(3): 598-634. doi: 10.1093/jalm/jfad007. DOI: https://doi.org/10.1093/jalm/jfad007
He RR, Yue GL, Dong ML, Wang JQ, Cheng C. Sepsis Biomarkers: Advancements and Clinical Applications, A Narrative Review. International Journal of Molecular Sciences. 2024 Aug; 25(16): 1-30. doi: 10.3390/ijms25169010. DOI: https://doi.org/10.3390/ijms25169010
Chen Y, Shen J, Yang H, Xu S, Ma Y, Pan F. Serum Procalcitonin and C-Reactive Protein Levels as Diagnostic Markers for Distinguishing Bacterial Infections from Lupus Flares in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. International Immunopharmacology. 2021 Dec; 101: 108304. doi: 10.1016/j.intimp.2021.108304. DOI: https://doi.org/10.1016/j.intimp.2021.108304
Khilnani GC, Tiwari P, Zirpe KG, Chaudhry D, Govil D, Dixit S, et al. Guidelines for the Use of Procalcitonin for Rational Use of Antibiotics. Indian Journal of Critical Care Medicine: Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine. 2022 Oct; 26(2): 1-18. doi: 10.5005/jp-journals-10071-24326. DOI: https://doi.org/10.5005/jp-journals-10071-24326
Fugit RV, McCoury JB, Bessesen MT. Procalcitonin for Sepsis Management: Implementation Within an Antimicrobial Stewardship Program. American Journal of Health-System Pharmacy. 2023 Jun; 80(2): 49-54. doi: 10.1093/ajhp/zxac341. DOI: https://doi.org/10.1093/ajhp/zxac341
Li Q, Yan W, Liu S, Li H. Study on The Correlation and Clinical Significance of T-Lymphocyte Subsets, IL-6, and PCT in The Severity of Patients with Sepsis. Pakistan Journal of Medical Sciences. 2023 Jan; 39(1): 227. doi: 10.12669/pjms.39.1.5711. DOI: https://doi.org/10.12669/pjms.39.1.5711
Niggli C, Vetter P, Hambrecht J, Pape HC, Mica L. Sex Differences in the Time Trends of Sepsis Biomarkers Following Polytrauma. Scientific Reports. 2025 Jan; 15(1): 1-5. doi: 10.1038/s41598-025-86495-w. DOI: https://doi.org/10.1038/s41598-025-86495-w
Russo A, Salini S, Gava G, Merra G, Piccioni A, De Matteis G et al. Reduced Prognostic Role of Serum Procalcitonin Measurement in Very Frail Older Adults Admitted to the Emergency Department. Antibiotics. 2023 Jun; 12(6): 1-14. doi: 10.3390/antibiotics12061036. DOI: https://doi.org/10.3390/antibiotics12061036
Póvoa P, Coelho L, Cidade JP, Ceccato A, Morris AC, Salluh J et al. Biomarkers in pulmonary infections: a clinical approach. Annals of Intensive Care. 2024 Jul; 14(1): 1-15. doi: 10.1186/s13613-024-01323-0. DOI: https://doi.org/10.1186/s13613-024-01323-0
Tian T, Wei B, Wang J. Study of C-Reactive Protein, Procalcitonin, and Immunocyte Ratios in 194 Patients With Sepsis. Biomed Central Emergency Medicine. 2021 Jul; 21(1): 1-8. doi: 10.1186/s12873-021-00477-5. DOI: https://doi.org/10.1186/s12873-021-00477-5
Wang YR, Zheng QB, Wei GF, Meng LJ, Feng QL, Yuan WJ et al. Elevated Procalcitonin at Intensive Care Unit Discharge Predicts Poor Prognosis in Patients with Severe Traumatic Brain Injury: A Retrospective Cohort Study. Journal of International Medical Research. 2020 May; 48(5): 1-11. doi: 10.1177/0300060520922456. DOI: https://doi.org/10.1177/0300060520922456
Milenkovic M, Hadzibegovic A, Kovac M, Jovanovic B, Stanisavljevic J, Djikic M et al. D‐Dimer, C-Reactive Protein, Procalcitonin, And IL‐6 Levels at Admission to Intensive Care Unit Can Predict In‐Hospital Mortality in Patients With COVID‐19 Pneumonia. Oxidative Medicine and Cellular Longevity. 2022 Jan; 2022(1): 1-9. doi: 10.1155/2022/8997709. DOI: https://doi.org/10.1155/2022/8997709
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
